Endotoxin in Recombinant Proteins — Why It Matters and How to Control It

Endotoxin contamination in recombinant proteins can activate immune cells, confound cell-based assays, and cause lethal toxicity in animal studies. Understanding why endotoxin matters and how to control it is essential for any protein production project intended for functional or in vivo use.

Cell-based assays: Endotoxin activates monocytes, macrophages, and dendritic cells via TLR4, confounding any experiment involving immune cells, cytokine readouts, or cell viability.

Animal studies: Endotoxin at >5 EU/kg body weight can cause fever, shock, and death in rodents. Any protein used for in vivo injection must be rigorously tested.

False positives: Apparent “biological activity” of a recombinant protein may actually be endotoxin-driven TLR4 activation rather than target-specific signaling.

Regulatory requirements: Preclinical and clinical-grade proteins have strict endotoxin limits (typically <1 EU/mg for in vivo use).

Polymyxin B affinity chromatography: Polymyxin B binds the lipid A moiety of LPS. Effective but may co-remove some target proteins.

Triton X-114 phase separation: LPS partitions into the detergent phase at 37 °C. Simple and inexpensive but requires multiple rounds for low-endotoxin targets.

Anion exchange chromatography: LPS is highly negatively charged and binds strongly to anion exchangers at neutral pH, separating from many target proteins.

Mammalian/insect expression: Avoid the problem entirely — eukaryotic expression systems do not produce endotoxin. Recommended when endotoxin-free protein is non-negotiable.

Need endotoxin-free recombinant proteins for cell-based assays or animal studies? AtaGenix delivers <0.1 EU/mL across E. coli, mammalian, and insect cell platforms with LAL-tested QC documentation.

Response within 24 hours